Previous studies demonstrated that, in pancreatic ductal adenocarcinoma, TLR2 and TLR4 serve as positive predictors of prognosis in stage I and II disease and in patients with small-size tumors [33]. Here, TLR4 is linked to pancreatic ductal adenocarcinoma.